Further development/co-development of SPL7013 opthalmic drops
That was actually from the May 2020 shareholder update @dannyleb. Fast forward to the April 2021 update and surprise surprise out it comes again.
Why then, when I asked the question about this initiative at the AGM did JF reply that they were not working on this. I cannot remember her exact words but that was the essence. Can anyone else shed light on her wording?
This being the case these types of claims are misleading and deceptive. It may be on the agenda but from a shareholders perspective the conclusion anyone would draw is that it's active and on going.
Conclusion --- Beware of claims and statements coming from HQ!!!
SPL Price at posting:
$1.35 Sentiment: Buy Disclosure: Held
